BSE Live
Nov 19, 13:40Prev. Close
329.45
Open Price
331.15
Bid Price (Qty.)
327.20 (4)
Offer Price (Qty.)
327.80 (15)
NSE Live
Nov 19, 13:40Prev. Close
330.40
Open Price
330.40
Bid Price (Qty.)
327.20 (5)
Offer Price (Qty.)
327.25 (2)
| Balance Sheet of Advanced Enzyme Technologies (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 22.34 | 22.33 | 22.33 | 22.33 | 21.77 | |
| Total Share Capital | 22.34 | 22.33 | 22.33 | 22.33 | 21.77 | |
| Reserves and Surplus | 344.54 | 293.62 | 266.57 | 232.90 | 153.08 | |
| Total Reserves and Surplus | 344.54 | 293.62 | 266.57 | 232.90 | 153.08 | |
| Total Shareholders Funds | 370.48 | 319.47 | 288.90 | 255.23 | 174.85 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 0.76 | 1.70 | 7.95 | 12.13 | 15.60 | |
| Deferred Tax Liabilities [Net] | 9.03 | 3.85 | 1.53 | 2.25 | 15.76 | |
| Other Long Term Liabilities | 0.21 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Provisions | 1.08 | 0.51 | 0.56 | 0.70 | 0.18 | |
| Total Non-Current Liabilities | 11.09 | 6.06 | 10.03 | 15.08 | 31.54 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 7.86 | 16.51 | 32.33 | 21.13 | 29.45 | |
| Trade Payables | 13.71 | 15.58 | 21.20 | 8.48 | 9.78 | |
| Other Current Liabilities | 17.83 | 16.60 | 18.75 | 16.00 | 13.41 | |
| Short Term Provisions | 1.71 | 1.66 | 1.80 | 1.61 | 2.52 | |
| Total Current Liabilities | 41.11 | 50.36 | 74.08 | 47.22 | 55.17 | |
| Total Capital And Liabilities | 422.68 | 375.89 | 373.00 | 317.53 | 261.55 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 125.16 | 95.02 | 97.61 | 98.24 | 101.23 | |
| Intangible Assets | 1.79 | 2.33 | 0.27 | 0.14 | 0.05 | |
| Capital Work-In-Progress | 4.58 | 1.26 | 2.43 | 1.50 | 1.84 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 136.91 | 104.35 | 108.18 | 106.42 | 109.32 | |
| Non-Current Investments | 119.85 | 120.46 | 120.04 | 103.41 | 53.08 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 26.52 | 35.54 | 29.35 | 1.37 | 17.82 | |
| Other Non-Current Assets | 9.22 | 8.54 | 6.44 | 6.07 | 0.13 | |
| Total Non-Current Assets | 292.50 | 268.89 | 264.00 | 217.27 | 180.34 | |
| CURRENT ASSETS | ||||||
| Current Investments | 1.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 59.65 | 58.62 | 54.86 | 51.06 | 47.40 | |
| Trade Receivables | 51.89 | 38.15 | 38.58 | 30.97 | 22.78 | |
| Cash And Cash Equivalents | 3.03 | 0.54 | 0.48 | 0.60 | 1.54 | |
| Short Term Loans And Advances | 0.02 | 0.02 | 2.06 | 2.07 | 2.84 | |
| OtherCurrentAssets | 14.59 | 9.67 | 13.02 | 15.57 | 6.65 | |
| Total Current Assets | 130.18 | 107.00 | 109.00 | 100.26 | 81.20 | |
| Total Assets | 422.68 | 375.89 | 373.00 | 317.53 | 261.55 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 16.05 | 30.86 | 30.45 | 26.01 | 19.84 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 22.94 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 1.16 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 26.90 | 28.58 | 24.25 | 24.25 | 2.13 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | 0.53 | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | 72.85 | 66.90 | 55.78 | 55.78 | 45.95 | |
| Other Earnings | -- | -- | -- | -- | 0.16 | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 15.55 | 15.55 | 15.55 | 15.55 | 15.55 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | 0.06 | 0.06 | 120.04 | 103.41 | 53.08 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | 1.00 | -- | -- | -- | -- |
19.11.2025
Advanced Enzyme Consolidated September 2025 Net Sales at Rs 184.53 crore, up 26.31% Y-o-Y
13.11.2025
Advanced Enzyme Standalone September 2025 Net Sales at Rs 115.75 crore, up 49.59% Y-o-Y
29.08.2025
Rohit Sharma sells 0.5% stake in Reliable Data Services after 73% surge in current week
28.08.2025
19.11.2025
Advanced Enzyme Consolidated September 2025 Net Sales at Rs 184.53 crore, up 26.31% Y-o-Y
13.11.2025
Advanced Enzyme Standalone September 2025 Net Sales at Rs 115.75 crore, up 49.59% Y-o-Y
05.08.2025
Advanced Enzyme Consolidated June 2025 Net Sales at Rs 185.91 crore, up 20.31% Y-o-Y
05.08.2025
Advanced Enzyme Standalone June 2025 Net Sales at Rs 125.02 crore, up 45.45% Y-o-Y